Department of Otolaryngology-Head and Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah.
Department of Surgery, University of Utah School of Medicine, Salt Lake City, Utah.
Int Forum Allergy Rhinol. 2020 Mar;10(3):381-387. doi: 10.1002/alr.22478. Epub 2019 Nov 6.
Excess opioid use after surgery contributes to opiate misuse and diversion. Understanding opioid prescribing and utilization patterns after sinonasal surgery is critical in designing effective practice protocols. In this study we aim to identify factors associated with variable opioid usage and further delineate optimal prescription patterns for sinonasal surgery.
All patients undergoing sinonasal surgery within a single health-care system from March 2017 to August 2018 were sent electronic postoperative surveys. Data were collected on the amount of opioid required, pain control, presurgical opiate use, and narcotic disposal. Additional data collected from the electronic medical record included demographics, type of surgery performed, and total amount of opioid prescribed, including refills.
Three-hundred sixty four patients were included. A mean number of 25.3 tablets were prescribed per patient, yet the mean taken was just 11.8 tablets. Excess opioids were prescribed 84.9% of the time with a mean excess narcotic in oral morphine equivalents of 152.5. Among patients, 11.8% reported using no opioids, whereas 52.1% used <50% and 36.1% used >50% of their narcotic prescription. Patients used 9.3% of their full prescription and only 2.6% required a refill. The amount used was not associated with complexity of endoscopic sinus surgery, type of opiate prescribed, gender, distance living from hospital, or current opioid usage before surgery (p > 0.05). The addition of septoplasty and/or turbinoplasty was associated with variation in opioid usage (p < 0.001). A total of 76.1% of patients incorrectly discarded/stored excess opiates.
Opioids are overprescribed after sinonasal surgery. The amount of postoperative opiate prescribed should be greatly reduced and may be based on the specific procedures performed. Improved patient education regarding disposal of excess narcotics may help to curtail future opioid diversion.
手术后过量使用阿片类药物会导致阿片类药物滥用和转移。了解鼻-鼻窦手术后阿片类药物的开具和使用模式对于制定有效的实践方案至关重要。在这项研究中,我们旨在确定与可变阿片类药物使用相关的因素,并进一步确定鼻-鼻窦手术的最佳处方模式。
在单一医疗保健系统内,从 2017 年 3 月至 2018 年 8 月,对所有接受鼻-鼻窦手术的患者发送电子术后问卷调查。收集的数据包括所需的阿片类药物量、疼痛控制、术前阿片类药物使用情况和阿片类药物处置情况。从电子病历中收集的其他数据包括人口统计学数据、所进行的手术类型以及开具的阿片类药物总量,包括续方。
共纳入 364 例患者。每位患者平均开具 25.3 片,但平均服用 11.8 片。84.9%的患者开具了过量的阿片类药物,口服吗啡当量的平均过量阿片类药物为 152.5。11.8%的患者报告未使用阿片类药物,52.1%的患者使用<50%的阿片类药物处方,36.1%的患者使用>50%的阿片类药物处方。患者使用了其全部处方的 9.3%,仅 2.6%需要续方。使用量与内镜鼻窦手术的复杂性、开具的阿片类药物类型、性别、与医院的距离或术前的阿片类药物使用无关(p>0.05)。鼻中隔成形术和/或鼻甲成形术的添加与阿片类药物使用的变化相关(p<0.001)。共有 76.1%的患者错误地丢弃/储存了多余的阿片类药物。
鼻-鼻窦手术后阿片类药物开具过多。术后阿片类药物的开具量应大大减少,可根据具体手术方式确定。加强患者关于多余麻醉剂处置的教育可能有助于遏制未来的阿片类药物滥用。